Thomas Smith, M.D.

Thomas Smith, M.D.

Executive Vice President and Chief Medical OfficeratCollegium Pharmaceutical· In proxies 2021–2025

Pay in FY2025-2% from the year before · Collegium Pharmaceutical stock +61.6% the same year

Thomas Smith, M.D. was paid $2.4M in FY2025 (Dec), down 2%. Collegium Pharmaceutical stock rose 61.6% that year.

Pay$100 in the stock at the end of FY20 → $231
Pay is from the Summary Compensation Table of each Collegium Pharmaceutical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Collegium PharmaceuticalPublic company · 5 yr
    • Executive Vice President and Chief Medical Officer2021 – Present · 5 yrStock in role +25%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?